Mankind Pharma IPO opened for subscription on 25 April and the issue has been booked 0.87 times on day 2, with total bids of 2,45,19,352 shares. Qualified institutional buyers (QIBs) subscribed for 186% of their reserved portion, demonstrating high interest in the issue. Retail investors bid only 0.25 times of the shares reserved for RIIs. […]
